Forget labs and microscopes: 3 Israeli startups aim to disrupt the field of blood testing using advanced technologies that give on-the-spot results. The way blood-cell counts and diagnostic blood tests are done hasn’t changed in years: Your blood gets drawn into one vial for each type of test and sent Leggi tutto…
Virtual reality has become a booming business. The technology has already proven its worth in real estate and banking. In healthcare, VR also shows big promise. According to Statista, the virtual reality healthcare market was valued at $976 million in 2017. But what are its use cases? Below are some Leggi tutto…
The sprawling US health care industry has trouble managing patient information: Every doctor, medical office, hospital, pharmacy, therapist and insurance company needs different pieces of data to properly care for patients. These records are scattered all over on each business’s computers—and some no doubt in filing cabinets too. They’re not all Leggi tutto…
Bedside robots could do swathes of the work now done by doctors and nurses, saving the NHS almost £13bn a year – a tenth of its budget – a major report says today. The controversial study led by surgeon and former health minister Lord Darzi calls for the “full automation” of health and social Leggi tutto…
Unique Israeli external orthopedic fixation system allows for objective measurement, ease of use and peace of mind for orthopedic patients. After performing complex surgery to correct a leg-bone deformity in a 15-year-old from Jerusalem, pediatric orthopedic surgeon Dr. Eitan Segev explained to the patient and his parents that they now Leggi tutto…
ISRAEL21c takes a look at some of the brightest and best new health startups on show at last week’s MIXiii-Biomed conference. If there’s one conference every year that is guaranteed to highlight fascinating new health innovations, it’s Israel’s MIXiii-Biomed, held last week in Tel Aviv. This annual three-day life-science and biomed conference Leggi tutto…
Tested so far on mice, Dr. Eitan Okun’s vaccine targets amyloid beta protein, which clusters in the brains of people affected by the deadly disease. By Abigail Klein Leichman Alzheimer’s disease, affecting some 47 million people worldwide, for now remains an irreversible and fatal brain disorder. Taking a proactive approach, Leggi tutto…